WallStreetZenWallStreetZen

NASDAQ: AVBP
Arrivent Biopharma Inc Earnings & Revenue

AVBP earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$69.3M
Current Profit Margin
0%

AVBP Return on Equity

Insufficient data to display

Be the first to know when AVBP announces earnings.

AVBP Return on Assets

Current Company
-40.1%
Current Industry
2.9%
AVBP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AVBP Return on Capital Employed

Current Company
-45.77%
Current Industry
19.5%

AVBP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AVBP$0.00-$69.33M-$69.33MN/AN/A
HUMA$0.00-$96.41M-$110.78M-100.00%N/A
CDMO$136.74M-$7.83M-$17.98M+25.75%N/A
URGN$82.71M-$81.90M-$102.24M+136.08%N/A
CELC$0.00-$58.31M-$63.78MN/AN/A

Arrivent Biopharma Earnings & Revenue FAQ

What were AVBP's earnings last quarter?

Arrivent Biopharma (NASDAQ: AVBP) reported Q4 2023 earnings per share (EPS) of -$7.69, up 5.76% year over year. Total Arrivent Biopharma earnings for the quarter were -$21.19 million. In the same quarter last year, Arrivent Biopharma's earnings per share (EPS) was -$8.16.

If you're new to stock investing, here's how to buy Arrivent Biopharma stock.

What was AVBP's earnings growth in the past year?

As of Q2 2024, Arrivent Biopharma's earnings has grown year over year. Arrivent Biopharma's earnings in the past year totalled -$69.33 million.

What was AVBP's revenue last quarter?

Arrivent Biopharma (NASDAQ: AVBP) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Arrivent Biopharma's revenue was $0.00.

What was AVBP's revenue growth in the past year?

As of Q2 2024, Arrivent Biopharma's revenue has grown null year over year. Arrivent Biopharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.